Ferritin and Thyroid Hormone Action
Endocrinology & Metabolism, Vol 61, 672-676, Copyright © 1985 by
Endocrine Society
Serum ferritin as a marker of thyroid hormone action on peripheral
tissues
J Takamatsu, M Majima, K Miki, K Kuma and T Mozai
Serum ferritin measurements were evaluated as a marker of thyroid
hormone action on peripheral tissues. Mean serum ferritin
concentrations were not significantly different in euthyroid,
thyrotoxic, and hypothyroid subjects due to a wide spread in
ferritin levels among individuals. Intraindividual changes in serum
ferritin, however, occurred with changing thyroid function. All 18
patients with thyrotoxic Graves' disease had a decrease in serum
ferritin levels when they became euthyroid during antithyroid drug
therapy. Furthermore, a significant intraindividual correlation
between serum levels of ferritin and T4 or T3 was found in 2
patients with thyrotoxic Graves' disease in whom levels were
measured serially throughout the course of therapy. Similarly, serum
ferritin levels increased in all 12 hypothyroid patients with
Hashimoto's disease when euthyroidism was achieved with L-T4
therapy. Administration of 75 micrograms T3 daily for 1 week to 11
euthyroid subjects resulted in a 23-243% (mean +/- SD, 117 +/- 70%)
increase in serum ferritin above basal values. In contrast, in 3
patients with thyroid hormone resistance, the same treatment
produced rises in serum ferritin concentrations of only 2%, 5%, and
15%. Our data suggest that alterations in thyroid status in a given
individual produce changes in serum ferritin levels. Measurement of
this protein before and after T3 therapy may prove useful in the
diagnosis of thyroid hormone resistance.
Study was published in '85 but still food for thought.
